MALS with SEC improves the efficiencies of the analysis of bionanoparticles that are difficult to be differentiated from the impurities during the purification process.
Pharma 4.0 and the Digital Regulated Laboratory Part 3: Quick Wins and Implementing Projects
December 1st 2022This is the final in a series of three eBooks discussing and offering practical advice on the journey from current ways of working to a digital laboratory operating in a regulated environment. Learn more about: